Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	31.11	18.73	14.29
Graham Fair Price	-8.00	120.62	131.10
PEG	-100.00	-0.20	0.00
Price/Book	3.01	0.26	0.26
Price/Cash Flow	53.30	-149.97	97.83
Prices/Earnings	28.19	3.51	2.74
Price/Sales	51.87	13.31	8.76
Price/FCF	53.30	-149.97	97.83
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.87	1.00	0.99
Operating Margin	-99.20	< 0.005	0.88
ROA	-19.36	0.02	0.02
ROE	0.02	0.02	-19.64
ROIC	0.02	< 0.005	-99.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	1007.55	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.09	-1.01	-1019.00
EPS QOQ	0.00	-0.17	-100.00
FCF QOQ	-0.54	-1.69	-213.08
Revenue QOQ	0.19	-0.30	55.97
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	64.29	0.00	inf
Days Sales Outstanding (DSO)	0.17	0.24	43.66
Inventory Turnover	1.40	0.00	inf
Debt/Capitalization	0.11	0.11	-2.42
Quick Ratio	7.43	8.61	15.86
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	180.66	185.41	2.63
Cash	3.31	2.94	-11.23
Capex	-0.11	0.00	inf
Free Cash Flow	0.47	-0.33	-31.03
Revenue	5.29	3.68	-30.39
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	7.52	8.63	14.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.36	5.46	25.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating